Joseph Broderick, MD
Neurology · Cincinnati, OHNPI 1609817642
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $21,648 of the $31,261 with a category attached, or 69.2%. F. Hoffmann-la Roche AG accounts for 67.8% of it on its own, with 4 other manufacturers making up the rest. 2024 is the largest year on record at $19,544, more than ten times the $1,767 reported in 2019.
Across 22 payments — averaging $1420.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- F. Hoffmann-la Roche AG$21K
- Roche Products Limited$5K
- Genentech, Inc.$5K
- Sanofi$112
- E.r. Squibb & Sons, L.L.C.$30
Across 4 payments — averaging $46,655 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$184K
- F. Hoffmann-la Roche AG$2K
What the payments were for
- Consulting fees$21,64869%
- Speaking & faculty fees$1,7676%
- Travel & lodging$7,59824%
- Food & beverage$2181%
- Education$300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| F. Hoffmann-la Roche AG | 11 | $21,199 |
| Roche Products Limited | 3 | $5,120 |
| Genentech, Inc. | 5 | $4,800 |
| Sanofi | 1 | $112 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$31,261 in reported general payments places this provider in the 80th percentile of 702 neurology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Avonex (4 Pack)Interferon Beta-1a | 16 | $213,884 |
| EliquisApixaban | 32 | $23,469 |
| XareltoRivaroxaban | 27 | $15,779 |
| Levetiracetam | 51 | $1,506 |
| Gabapentin | 112 | $1,339 |
| Donepezil Hcl | 52 | $428 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 28 | $409 |
| Topiramate | 21 | $394 |
| Baclofen | 18 | $323 |
| Primidone | 20 | $242 |
| Bupropion Hcl | 12 | $204 |
| Atorvastatin Calcium | 14 | $121 |
| Pregabalin | 13 | $83 |
| Fluoxetine Hcl | 13 | $14 |
Paid to pharmacies, not to this prescriber.
Other neurology in Cincinnati
- Aram ZabetiCincinnati$1.6M
- Brandon ForemanCincinnati$385K
- Alberto EspayCincinnati$351K
- Michael PriviteraCincinnati$243K
- Brian MoseleyCincinnati$220K
- Zainab ContractorCincinnati$181K
- Reena ShahCincinnati$180K
- Marsha SmithCincinnati$178K
- David SchmerlerCincinnati$162K
- Hani KushlafCincinnati$115K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.